Detoxification is a process of removing unwanted substances or toxins from the body—this is what the body does naturally. Detox products aid in the improvement of body functions by reducing the contents of toxins in the body at the same time using certain detox products to support the detoxification process. Furthermore, people going through withdrawal of certain drug habits use detox products, which are given under medical supervision and rehabilitation centers. While most of the pharmaceuticals used in the detox treatment are strictly prescribed by physicians only, herbal detoxification is widely available as over-the-counter products. Herbal products such as dietary supplements and green tea are increasingly being used to detoxify the body.
COVID-19 Impact Analysis
- COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
- Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global detox products market.
Top Impacting Factors
With increasing prevalence of chronic diseases, the number of people addicted with opioids has also increased significantly.
Changing lifestyle and increasing population are some factors that boost the detox products market growth.
In addition, rising awareness about detoxification products and their potential health benefits such as improved blood circulation and rejuvenation of the skin has increased demand for detox products.
Furthermore, consumer preference toward health supplement is fueling the growth of the market.
Increasing presence of nicotine replacement therapy products such as chewing gums is fueling the demand for detox products.
Market Trends
New Product Launches to Flourish the Market
In April 2018, Sandoz (a division of Novartis) signed an agreement with Pear Therapeutics to develop and market digital prescription therapies for patients with substance use disorder and opioid use disorders.
In May 2019, Himalaya Global Holdings Ltd. announced that it will introduce a new research center in Dubai. While the research center is expected to be launched in 2021, this move is supposed to back the rise in research and development activities in the detox products market. In addition to this, it will aid in making the company’s position strong in the global detox products market.
In August 2019, GSK and Pfizer combined their respective consumer healthcare businesses into a global joint venture. The goal would be to complete the integration of these two companies and to exploit the combined strength.
Surge in Usage of Detox Products
- Increasing usage of detox products such as herbs, tea, colon cleanses, and enemas and supplements in weight management programs. The herbal segment is looking at improved demand, especially the green tea segment. It has numerous health benefits for smokers, who are creating a high demand for the product in the market. Rising awareness regarding the harmful effect of drugs, alcohol, and cigarettes, and various preventive major taken by the various governments to reduce drug consumption is driving the number of people visiting clinics and rehabilitation centers. As a result, the demand for detox products has witnessed substantial growth.
Key Benefits of the Report
- This study presents the analytical depiction of the detox products market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the detox products market share.
- The current market is quantitatively analyzed to highlight the detox products market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Detox Products Market Report
- Which are the leading market players active in the detox products market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is detox products market?
- What is detox products market prediction in the future?
- Who are the leading global players in the detox products market?
- What are the current trends and predicted trends?
- What are the key benefits of the detox products market report?
Key Market Segments
- By Type
- Pharmaceutical Detox Products
- Herbal Detox Products
- Cosmetic Detox Products
- By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Mallinckrodt PLC.,
- Sun Pharmaceutical Industries Ltd.,
- Pfizer Inc.,
- Novartis AG.,
- West-Ward Pharmaceuticals Corp.,
- Valeant Pharmaceuticals International Inc.
- Biodelivery Sciences International Inc.,
- Teva Pharmaceutical Industries Ltd.,
- Daiichi Pharmaceutical Co.,
- Mylan N.V.,